Disseminated histoplasmosis: A comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals

Angela M. Tobón, Carlos A. Agudelo, David S. Rosero, Juan E. Ochoa, Catalina De Bedout, Alejandra Zuluaga, Myrtha Arango, Luz E. Cano, Jaime Sampedro, Angela Restrepo

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

We studied 52 patients with disseminated histoplasmosis, 30 with the acquired immunodeficiency syndrome (AIDS) (cohort 1) and 22 not co-infected with the human immunodeficiency virus (cohort 2). Demographic, clinical, laboratory, mycologic findings, as well as antifungal therapy and highly active antiretroviral (HAART), were analyzed. Skin lesions were significantly higher in cohort 1 than in cohort 2 (P = 0.001). Anemia, leukopenia, and an elevated erythrocyte sedimentation rate were also more pronounced in cohort 1 than in cohort 2 (P <0.001). Histoplasma capsulatum was isolated more often in cohort 1 than in cohort 2 (P <0.05) patients, but antibodies to H. capsulatum were detected more frequently in cohort 2 than in cohort 1 (P <0.05). Itraconazole treatment was less effective in cohort 1 than in cohort 2 (P = 0.012). In cohort 1 patients, HAART improved response to antifungals when compared with individuals not given HAART (P = 0.003), who exhibited higher mortality rates (P = 0.025). Cohort 1 patients who were given dual antifungal and anti-retroviral therapies responded as well as the non-HIV patients in cohort 2, who were treated only with itraconazole. These results indicate the need to promote restoration of the immune system in patients with AIDS and histoplasmosis.

Original languageEnglish
Pages (from-to)576-582
Number of pages7
JournalAmerican Journal of Tropical Medicine and Hygiene
Volume73
Issue number3
Publication statusPublished - Sep 2005

Fingerprint

Histoplasmosis
Acquired Immunodeficiency Syndrome
Viruses
Histoplasma
Itraconazole
HIV-2
Blood Sedimentation
Highly Active Antiretroviral Therapy
Leukopenia
Anemia
Immune System
Demography
Skin
Mortality
Antibodies
Therapeutics

ASJC Scopus subject areas

  • Parasitology
  • Infectious Diseases

Cite this

Disseminated histoplasmosis : A comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals. / Tobón, Angela M.; Agudelo, Carlos A.; Rosero, David S.; Ochoa, Juan E.; De Bedout, Catalina; Zuluaga, Alejandra; Arango, Myrtha; Cano, Luz E.; Sampedro, Jaime; Restrepo, Angela.

In: American Journal of Tropical Medicine and Hygiene, Vol. 73, No. 3, 09.2005, p. 576-582.

Research output: Contribution to journalArticle

Tobón, AM, Agudelo, CA, Rosero, DS, Ochoa, JE, De Bedout, C, Zuluaga, A, Arango, M, Cano, LE, Sampedro, J & Restrepo, A 2005, 'Disseminated histoplasmosis: A comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals', American Journal of Tropical Medicine and Hygiene, vol. 73, no. 3, pp. 576-582.
Tobón, Angela M. ; Agudelo, Carlos A. ; Rosero, David S. ; Ochoa, Juan E. ; De Bedout, Catalina ; Zuluaga, Alejandra ; Arango, Myrtha ; Cano, Luz E. ; Sampedro, Jaime ; Restrepo, Angela. / Disseminated histoplasmosis : A comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals. In: American Journal of Tropical Medicine and Hygiene. 2005 ; Vol. 73, No. 3. pp. 576-582.
@article{654707c7c3494e5ab90ee0d5fec3f6c0,
title = "Disseminated histoplasmosis: A comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals",
abstract = "We studied 52 patients with disseminated histoplasmosis, 30 with the acquired immunodeficiency syndrome (AIDS) (cohort 1) and 22 not co-infected with the human immunodeficiency virus (cohort 2). Demographic, clinical, laboratory, mycologic findings, as well as antifungal therapy and highly active antiretroviral (HAART), were analyzed. Skin lesions were significantly higher in cohort 1 than in cohort 2 (P = 0.001). Anemia, leukopenia, and an elevated erythrocyte sedimentation rate were also more pronounced in cohort 1 than in cohort 2 (P <0.001). Histoplasma capsulatum was isolated more often in cohort 1 than in cohort 2 (P <0.05) patients, but antibodies to H. capsulatum were detected more frequently in cohort 2 than in cohort 1 (P <0.05). Itraconazole treatment was less effective in cohort 1 than in cohort 2 (P = 0.012). In cohort 1 patients, HAART improved response to antifungals when compared with individuals not given HAART (P = 0.003), who exhibited higher mortality rates (P = 0.025). Cohort 1 patients who were given dual antifungal and anti-retroviral therapies responded as well as the non-HIV patients in cohort 2, who were treated only with itraconazole. These results indicate the need to promote restoration of the immune system in patients with AIDS and histoplasmosis.",
author = "Tob{\'o}n, {Angela M.} and Agudelo, {Carlos A.} and Rosero, {David S.} and Ochoa, {Juan E.} and {De Bedout}, Catalina and Alejandra Zuluaga and Myrtha Arango and Cano, {Luz E.} and Jaime Sampedro and Angela Restrepo",
year = "2005",
month = "9",
language = "English",
volume = "73",
pages = "576--582",
journal = "American Journal of Tropical Medicine and Hygiene",
issn = "0002-9637",
publisher = "American Society of Tropical Medicine and Hygiene",
number = "3",

}

TY - JOUR

T1 - Disseminated histoplasmosis

T2 - A comparative study between patients with acquired immunodeficiency syndrome and non-human immunodeficiency virus-infected individuals

AU - Tobón, Angela M.

AU - Agudelo, Carlos A.

AU - Rosero, David S.

AU - Ochoa, Juan E.

AU - De Bedout, Catalina

AU - Zuluaga, Alejandra

AU - Arango, Myrtha

AU - Cano, Luz E.

AU - Sampedro, Jaime

AU - Restrepo, Angela

PY - 2005/9

Y1 - 2005/9

N2 - We studied 52 patients with disseminated histoplasmosis, 30 with the acquired immunodeficiency syndrome (AIDS) (cohort 1) and 22 not co-infected with the human immunodeficiency virus (cohort 2). Demographic, clinical, laboratory, mycologic findings, as well as antifungal therapy and highly active antiretroviral (HAART), were analyzed. Skin lesions were significantly higher in cohort 1 than in cohort 2 (P = 0.001). Anemia, leukopenia, and an elevated erythrocyte sedimentation rate were also more pronounced in cohort 1 than in cohort 2 (P <0.001). Histoplasma capsulatum was isolated more often in cohort 1 than in cohort 2 (P <0.05) patients, but antibodies to H. capsulatum were detected more frequently in cohort 2 than in cohort 1 (P <0.05). Itraconazole treatment was less effective in cohort 1 than in cohort 2 (P = 0.012). In cohort 1 patients, HAART improved response to antifungals when compared with individuals not given HAART (P = 0.003), who exhibited higher mortality rates (P = 0.025). Cohort 1 patients who were given dual antifungal and anti-retroviral therapies responded as well as the non-HIV patients in cohort 2, who were treated only with itraconazole. These results indicate the need to promote restoration of the immune system in patients with AIDS and histoplasmosis.

AB - We studied 52 patients with disseminated histoplasmosis, 30 with the acquired immunodeficiency syndrome (AIDS) (cohort 1) and 22 not co-infected with the human immunodeficiency virus (cohort 2). Demographic, clinical, laboratory, mycologic findings, as well as antifungal therapy and highly active antiretroviral (HAART), were analyzed. Skin lesions were significantly higher in cohort 1 than in cohort 2 (P = 0.001). Anemia, leukopenia, and an elevated erythrocyte sedimentation rate were also more pronounced in cohort 1 than in cohort 2 (P <0.001). Histoplasma capsulatum was isolated more often in cohort 1 than in cohort 2 (P <0.05) patients, but antibodies to H. capsulatum were detected more frequently in cohort 2 than in cohort 1 (P <0.05). Itraconazole treatment was less effective in cohort 1 than in cohort 2 (P = 0.012). In cohort 1 patients, HAART improved response to antifungals when compared with individuals not given HAART (P = 0.003), who exhibited higher mortality rates (P = 0.025). Cohort 1 patients who were given dual antifungal and anti-retroviral therapies responded as well as the non-HIV patients in cohort 2, who were treated only with itraconazole. These results indicate the need to promote restoration of the immune system in patients with AIDS and histoplasmosis.

UR - http://www.scopus.com/inward/record.url?scp=24944560979&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24944560979&partnerID=8YFLogxK

M3 - Article

C2 - 16172484

AN - SCOPUS:24944560979

VL - 73

SP - 576

EP - 582

JO - American Journal of Tropical Medicine and Hygiene

JF - American Journal of Tropical Medicine and Hygiene

SN - 0002-9637

IS - 3

ER -